

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.32397954 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.28622642 |
| 3 | synaptic vesicle maturation (GO:0016188) | 6.19770865 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.89629172 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.49296405 |
| 6 | vocalization behavior (GO:0071625) | 5.44797887 |
| 7 | central nervous system myelination (GO:0022010) | 5.43218366 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 5.43218366 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.40555332 |
| 10 | glutamate secretion (GO:0014047) | 5.29994261 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 5.28454366 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.19867909 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.09438715 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.96399569 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.76613029 |
| 16 | protein localization to synapse (GO:0035418) | 4.66412487 |
| 17 | exploration behavior (GO:0035640) | 4.65459820 |
| 18 | neuronal action potential propagation (GO:0019227) | 4.57605293 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.57407292 |
| 20 | presynaptic membrane organization (GO:0097090) | 4.56554867 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 4.53842575 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.53171024 |
| 23 | presynaptic membrane assembly (GO:0097105) | 4.47899425 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.46924462 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.43168301 |
| 26 | synaptic transmission, glutamatergic (GO:0035249) | 4.36944363 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.36451444 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 4.36443962 |
| 29 | glutamate receptor signaling pathway (GO:0007215) | 4.30522346 |
| 30 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.22767880 |
| 31 | amino acid import (GO:0043090) | 4.20631501 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 4.14013720 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 4.11335311 |
| 34 | auditory behavior (GO:0031223) | 4.05065272 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 4.02978772 |
| 36 | neuron-neuron synaptic transmission (GO:0007270) | 3.98021796 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.94068239 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 3.92402839 |
| 39 | long-term memory (GO:0007616) | 3.89069190 |
| 40 | sodium ion export (GO:0071436) | 3.87944923 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87459538 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.86691599 |
| 43 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85906829 |
| 44 | proline transport (GO:0015824) | 3.84100053 |
| 45 | neuromuscular process controlling balance (GO:0050885) | 3.75966157 |
| 46 | response to auditory stimulus (GO:0010996) | 3.72816921 |
| 47 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.70437392 |
| 48 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.68256111 |
| 49 | potassium ion homeostasis (GO:0055075) | 3.67944076 |
| 50 | regulation of postsynaptic membrane potential (GO:0060078) | 3.64545147 |
| 51 | regulation of synaptic plasticity (GO:0048167) | 3.63739848 |
| 52 | neurotransmitter transport (GO:0006836) | 3.58762524 |
| 53 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.58013133 |
| 54 | activation of protein kinase A activity (GO:0034199) | 3.57861372 |
| 55 | transmission of nerve impulse (GO:0019226) | 3.55434858 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.55027437 |
| 57 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.51868280 |
| 58 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.51638690 |
| 59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.51552176 |
| 60 | synaptic vesicle endocytosis (GO:0048488) | 3.51378835 |
| 61 | glycine transport (GO:0015816) | 3.50543678 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46730589 |
| 63 | neurotransmitter uptake (GO:0001504) | 3.45461948 |
| 64 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.40927206 |
| 65 | innervation (GO:0060384) | 3.40925001 |
| 66 | long-term synaptic potentiation (GO:0060291) | 3.39745174 |
| 67 | cellular sodium ion homeostasis (GO:0006883) | 3.37402758 |
| 68 | startle response (GO:0001964) | 3.36738696 |
| 69 | acidic amino acid transport (GO:0015800) | 3.35405732 |
| 70 | dendrite morphogenesis (GO:0048813) | 3.34747577 |
| 71 | regulation of neurotransmitter levels (GO:0001505) | 3.33126304 |
| 72 | cell communication by electrical coupling (GO:0010644) | 3.32161486 |
| 73 | prepulse inhibition (GO:0060134) | 3.27985807 |
| 74 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.27525522 |
| 75 | L-amino acid import (GO:0043092) | 3.26877625 |
| 76 | neuron recognition (GO:0008038) | 3.26202464 |
| 77 | mechanosensory behavior (GO:0007638) | 3.25684463 |
| 78 | regulation of neurotransmitter transport (GO:0051588) | 3.24807078 |
| 79 | membrane depolarization during action potential (GO:0086010) | 3.23775216 |
| 80 | regulation of vesicle fusion (GO:0031338) | 3.21162879 |
| 81 | neuromuscular process controlling posture (GO:0050884) | 3.20800322 |
| 82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.20521672 |
| 83 | membrane depolarization (GO:0051899) | 3.19997970 |
| 84 | adult walking behavior (GO:0007628) | 3.19977588 |
| 85 | postsynaptic membrane organization (GO:0001941) | 3.19384145 |
| 86 | cerebellar granule cell differentiation (GO:0021707) | 3.18435150 |
| 87 | regulation of ARF protein signal transduction (GO:0032012) | 3.18017332 |
| 88 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.17095121 |
| 89 | membrane hyperpolarization (GO:0060081) | 3.16913031 |
| 90 | neuromuscular process (GO:0050905) | 3.16663530 |
| 91 | positive regulation of neurotransmitter transport (GO:0051590) | 3.15631948 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.13586290 |
| 93 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.12277971 |
| 94 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11274679 |
| 95 | neuronal ion channel clustering (GO:0045161) | 3.10852337 |
| 96 | C4-dicarboxylate transport (GO:0015740) | 3.09215169 |
| 97 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.09163977 |
| 98 | dendritic spine organization (GO:0097061) | 3.08850952 |
| 99 | serotonin metabolic process (GO:0042428) | 3.07896409 |
| 100 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.05362934 |
| 101 | synapse assembly (GO:0007416) | 3.05104253 |
| 102 | axonal fasciculation (GO:0007413) | 3.04932165 |
| 103 | neuromuscular synaptic transmission (GO:0007274) | 3.03867875 |
| 104 | regulation of dendritic spine development (GO:0060998) | 3.01268180 |
| 105 | regulation of synaptic transmission (GO:0050804) | 3.01149507 |
| 106 | L-glutamate transport (GO:0015813) | 3.01030225 |
| 107 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.00678368 |
| 108 | learning (GO:0007612) | 3.00279695 |
| 109 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.98051378 |
| 110 | positive regulation of synaptic transmission (GO:0050806) | 2.97445746 |
| 111 | detection of calcium ion (GO:0005513) | 2.95842971 |
| 112 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.94029153 |
| 113 | synaptic transmission (GO:0007268) | 2.93490285 |
| 114 | vesicle transport along microtubule (GO:0047496) | 2.93188910 |
| 115 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91817382 |
| 116 | potassium ion import (GO:0010107) | 2.91736099 |
| 117 | positive regulation of dendritic spine development (GO:0060999) | 2.91399530 |
| 118 | regulation of synapse maturation (GO:0090128) | 2.90076441 |
| 119 | chemosensory behavior (GO:0007635) | 2.89869428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.58823942 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.21971334 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10193797 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.05314769 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04598610 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.81061722 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74674900 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74674900 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.70687373 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.69942452 |
| 11 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.65074288 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58269803 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55851329 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55668747 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49289796 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45218978 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42513299 |
| 18 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.31320886 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29521148 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28078502 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27329791 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.26772202 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20864969 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13167790 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.08268430 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.06932953 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.06533437 |
| 28 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86798802 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83994164 |
| 30 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82845138 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.66307039 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63815872 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62474303 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55512813 |
| 35 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38353145 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36205747 |
| 37 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.34881065 |
| 38 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34806453 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33295788 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29518431 |
| 41 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29366187 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27255443 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26385065 |
| 44 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26126215 |
| 45 | * AR_19668381_ChIP-Seq_PC3_Human | 1.26063092 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23486433 |
| 47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22750714 |
| 48 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.21613082 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20843295 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20793932 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20787345 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17974413 |
| 53 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14448857 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13931489 |
| 55 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13899339 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13815803 |
| 57 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11872773 |
| 58 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11833160 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.10684017 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10596109 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10009337 |
| 62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09216129 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06631022 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05314181 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04365500 |
| 66 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04338427 |
| 67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04338427 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03749245 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03361433 |
| 70 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03277993 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03207912 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02746808 |
| 73 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02689569 |
| 74 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01496138 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01008146 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00910024 |
| 77 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00865503 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00203604 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99832099 |
| 80 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99372439 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99041389 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98023059 |
| 83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97813840 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97752800 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97162274 |
| 86 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96628319 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95131607 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94478914 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94318248 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94297261 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93888809 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93496387 |
| 93 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92971608 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92680344 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91981108 |
| 96 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91677896 |
| 97 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91620050 |
| 98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90848873 |
| 99 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90186261 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90102830 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89219709 |
| 102 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88130356 |
| 103 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88092925 |
| 104 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.87327289 |
| 105 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87314300 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86989891 |
| 107 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.86794381 |
| 108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86239968 |
| 109 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84917671 |
| 110 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84459262 |
| 111 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.84075894 |
| 112 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83922989 |
| 113 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.83909810 |
| 114 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83205093 |
| 115 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82995923 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82914723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.09234085 |
| 2 | MP0003880_abnormal_central_pattern | 4.52719925 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.30808078 |
| 4 | MP0004270_analgesia | 3.95182956 |
| 5 | MP0009745_abnormal_behavioral_response | 3.44891124 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.40440382 |
| 7 | MP0002064_seizures | 3.23330927 |
| 8 | MP0009046_muscle_twitch | 3.18815434 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.04364569 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.88799391 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.79273753 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.73214319 |
| 13 | MP0002272_abnormal_nervous_system | 2.67208671 |
| 14 | MP0001486_abnormal_startle_reflex | 2.64914974 |
| 15 | MP0002822_catalepsy | 2.57694595 |
| 16 | MP0002736_abnormal_nociception_after | 2.45184473 |
| 17 | MP0008569_lethality_at_weaning | 2.20866470 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.20238344 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.18127326 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.06319007 |
| 21 | MP0004858_abnormal_nervous_system | 2.05840122 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.03888733 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.02873352 |
| 24 | MP0001970_abnormal_pain_threshold | 1.97109068 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.96704517 |
| 26 | MP0003329_amyloid_beta_deposits | 1.93830216 |
| 27 | MP0004811_abnormal_neuron_physiology | 1.86227284 |
| 28 | MP0002184_abnormal_innervation | 1.84679875 |
| 29 | MP0000778_abnormal_nervous_system | 1.78110220 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.75777745 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.68441329 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.68040388 |
| 33 | MP0000955_abnormal_spinal_cord | 1.66607531 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.65427832 |
| 35 | MP0004924_abnormal_behavior | 1.65427832 |
| 36 | MP0003879_abnormal_hair_cell | 1.63703201 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.60797207 |
| 38 | MP0004885_abnormal_endolymph | 1.59592486 |
| 39 | MP0003633_abnormal_nervous_system | 1.48641669 |
| 40 | MP0002066_abnormal_motor_capabilities/c | 1.46442698 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.45878821 |
| 42 | MP0001984_abnormal_olfaction | 1.44528467 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.42401247 |
| 44 | MP0003283_abnormal_digestive_organ | 1.39065003 |
| 45 | MP0003631_nervous_system_phenotype | 1.29123013 |
| 46 | MP0004142_abnormal_muscle_tone | 1.26320248 |
| 47 | MP0003123_paternal_imprinting | 1.25615602 |
| 48 | MP0003787_abnormal_imprinting | 1.17969488 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.14940062 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.13238199 |
| 51 | MP0002152_abnormal_brain_morphology | 1.12658389 |
| 52 | MP0000920_abnormal_myelination | 1.09277423 |
| 53 | MP0001177_atelectasis | 1.03784823 |
| 54 | MP0003690_abnormal_glial_cell | 1.03625474 |
| 55 | MP0003632_abnormal_nervous_system | 1.03270937 |
| 56 | MP0002638_abnormal_pupillary_reflex | 1.03237296 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.02376966 |
| 58 | MP0006276_abnormal_autonomic_nervous | 1.02014999 |
| 59 | MP0003075_altered_response_to | 1.01404677 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.01066500 |
| 61 | MP0002229_neurodegeneration | 0.99437407 |
| 62 | MP0001905_abnormal_dopamine_level | 0.99301691 |
| 63 | MP0003634_abnormal_glial_cell | 0.98076259 |
| 64 | MP0004742_abnormal_vestibular_system | 0.97737641 |
| 65 | MP0008872_abnormal_physiological_respon | 0.95304600 |
| 66 | MP0001529_abnormal_vocalization | 0.92789812 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.91958160 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.90675290 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.90459930 |
| 70 | MP0004147_increased_porphyrin_level | 0.86627015 |
| 71 | MP0000604_amyloidosis | 0.86465631 |
| 72 | MP0008874_decreased_physiological_sensi | 0.85904014 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.80526759 |
| 74 | MP0000751_myopathy | 0.78718905 |
| 75 | MP0003122_maternal_imprinting | 0.78207197 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.76198766 |
| 77 | MP0002752_abnormal_somatic_nervous | 0.74991092 |
| 78 | MP0004043_abnormal_pH_regulation | 0.73286279 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.73095242 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.72641021 |
| 81 | MP0004085_abnormal_heartbeat | 0.71581226 |
| 82 | MP0005535_abnormal_body_temperature | 0.71549702 |
| 83 | MP0005394_taste/olfaction_phenotype | 0.70340721 |
| 84 | MP0005499_abnormal_olfactory_system | 0.70340721 |
| 85 | MP0005174_abnormal_tail_pigmentation | 0.69949747 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.68536401 |
| 87 | MP0003172_abnormal_lysosome_physiology | 0.68336912 |
| 88 | MP0001485_abnormal_pinna_reflex | 0.67657450 |
| 89 | MP0002090_abnormal_vision | 0.66215094 |
| 90 | MP0004130_abnormal_muscle_cell | 0.65565202 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.65156037 |
| 92 | MP0005187_abnormal_penis_morphology | 0.65141831 |
| 93 | MP0003137_abnormal_impulse_conducting | 0.64132412 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.64026288 |
| 95 | MP0004484_altered_response_of | 0.63903328 |
| 96 | MP0000026_abnormal_inner_ear | 0.62963119 |
| 97 | MP0005623_abnormal_meninges_morphology | 0.62377066 |
| 98 | MP0001299_abnormal_eye_distance/ | 0.62333913 |
| 99 | MP0004233_abnormal_muscle_weight | 0.61514747 |
| 100 | MP0003121_genomic_imprinting | 0.60664547 |
| 101 | MP0005171_absent_coat_pigmentation | 0.60544589 |
| 102 | MP0005410_abnormal_fertilization | 0.60387432 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.59268601 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.57544071 |
| 105 | MP0003861_abnormal_nervous_system | 0.56757276 |
| 106 | MP0010770_preweaning_lethality | 0.56149858 |
| 107 | MP0002082_postnatal_lethality | 0.56149858 |
| 108 | MP0010768_mortality/aging | 0.56029246 |
| 109 | MP0002876_abnormal_thyroid_physiology | 0.55656113 |
| 110 | MP0003045_fibrosis | 0.55063124 |
| 111 | MP0010769_abnormal_survival | 0.54593304 |
| 112 | MP0001188_hyperpigmentation | 0.54118536 |
| 113 | MP0001348_abnormal_lacrimal_gland | 0.54091376 |
| 114 | MP0004510_myositis | 0.53563009 |
| 115 | MP0001664_abnormal_digestion | 0.52544941 |
| 116 | MP0001943_abnormal_respiration | 0.52396839 |
| 117 | MP0003956_abnormal_body_size | 0.46967335 |
| 118 | MP0003698_abnormal_male_reproductive | 0.44770267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.31991487 |
| 2 | Focal motor seizures (HP:0011153) | 7.26849956 |
| 3 | Focal seizures (HP:0007359) | 5.65283185 |
| 4 | Visual hallucinations (HP:0002367) | 5.30645432 |
| 5 | Action tremor (HP:0002345) | 4.73715625 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.59570981 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.41689772 |
| 8 | Febrile seizures (HP:0002373) | 4.34920651 |
| 9 | Atonic seizures (HP:0010819) | 4.19833237 |
| 10 | Supranuclear gaze palsy (HP:0000605) | 3.87965508 |
| 11 | Absence seizures (HP:0002121) | 3.85045338 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.74690113 |
| 13 | Ankle clonus (HP:0011448) | 3.68360557 |
| 14 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.62890136 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.59616148 |
| 16 | Dialeptic seizures (HP:0011146) | 3.53047582 |
| 17 | Dysmetria (HP:0001310) | 3.39353008 |
| 18 | Broad-based gait (HP:0002136) | 3.36402184 |
| 19 | Limb dystonia (HP:0002451) | 3.36266006 |
| 20 | Dysdiadochokinesis (HP:0002075) | 3.34970251 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.34893393 |
| 22 | Postural instability (HP:0002172) | 3.29080441 |
| 23 | Poor eye contact (HP:0000817) | 3.25973944 |
| 24 | Depression (HP:0000716) | 3.24776855 |
| 25 | Cerebral hypomyelination (HP:0006808) | 3.21058751 |
| 26 | Abnormality of the lower motor neuron (HP:0002366) | 3.19826110 |
| 27 | Truncal ataxia (HP:0002078) | 3.12849210 |
| 28 | Mutism (HP:0002300) | 3.06342282 |
| 29 | Spastic gait (HP:0002064) | 3.01347597 |
| 30 | Anxiety (HP:0000739) | 3.01105497 |
| 31 | Impaired smooth pursuit (HP:0007772) | 2.95792542 |
| 32 | Abnormal social behavior (HP:0012433) | 2.93678567 |
| 33 | Impaired social interactions (HP:0000735) | 2.93678567 |
| 34 | Intention tremor (HP:0002080) | 2.92338866 |
| 35 | Urinary urgency (HP:0000012) | 2.88801247 |
| 36 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.84151882 |
| 37 | Ventricular fibrillation (HP:0001663) | 2.79475056 |
| 38 | Hemiplegia (HP:0002301) | 2.79288485 |
| 39 | Torticollis (HP:0000473) | 2.76850286 |
| 40 | Hemiparesis (HP:0001269) | 2.75104034 |
| 41 | Papilledema (HP:0001085) | 2.75087325 |
| 42 | Genetic anticipation (HP:0003743) | 2.74868248 |
| 43 | Hyperventilation (HP:0002883) | 2.72829643 |
| 44 | Megalencephaly (HP:0001355) | 2.72802563 |
| 45 | Scanning speech (HP:0002168) | 2.69045723 |
| 46 | Neurofibrillary tangles (HP:0002185) | 2.67623426 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.66878137 |
| 48 | Amblyopia (HP:0000646) | 2.59863419 |
| 49 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.57465154 |
| 50 | Annular pancreas (HP:0001734) | 2.56695133 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.55578696 |
| 52 | Diplopia (HP:0000651) | 2.55578696 |
| 53 | Cerebral inclusion bodies (HP:0100314) | 2.55454745 |
| 54 | Focal dystonia (HP:0004373) | 2.53893444 |
| 55 | Abnormality of the corticospinal tract (HP:0002492) | 2.52122554 |
| 56 | Bradykinesia (HP:0002067) | 2.49366431 |
| 57 | Impaired vibratory sensation (HP:0002495) | 2.47121115 |
| 58 | Stereotypic behavior (HP:0000733) | 2.46252907 |
| 59 | Dysmetric saccades (HP:0000641) | 2.44272296 |
| 60 | Delusions (HP:0000746) | 2.44055347 |
| 61 | Drooling (HP:0002307) | 2.43893955 |
| 62 | Excessive salivation (HP:0003781) | 2.43893955 |
| 63 | Spastic tetraparesis (HP:0001285) | 2.43549339 |
| 64 | Lower limb muscle weakness (HP:0007340) | 2.42188298 |
| 65 | Akinesia (HP:0002304) | 2.38431119 |
| 66 | Peripheral hypomyelination (HP:0007182) | 2.38040601 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.37821719 |
| 68 | Termporal pattern (HP:0011008) | 2.35950008 |
| 69 | Insidious onset (HP:0003587) | 2.35950008 |
| 70 | Pointed chin (HP:0000307) | 2.35929981 |
| 71 | Sleep apnea (HP:0010535) | 2.34968272 |
| 72 | Polyphagia (HP:0002591) | 2.34646613 |
| 73 | Progressive inability to walk (HP:0002505) | 2.33904983 |
| 74 | Epileptiform EEG discharges (HP:0011182) | 2.33385720 |
| 75 | Insomnia (HP:0100785) | 2.30635968 |
| 76 | EEG with generalized epileptiform discharges (HP:0011198) | 2.27132784 |
| 77 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.26162325 |
| 78 | Craniofacial dystonia (HP:0012179) | 2.23535215 |
| 79 | Absent speech (HP:0001344) | 2.20921752 |
| 80 | Status epilepticus (HP:0002133) | 2.20702682 |
| 81 | Bundle branch block (HP:0011710) | 2.18955359 |
| 82 | Clonus (HP:0002169) | 2.18557331 |
| 83 | Hypsarrhythmia (HP:0002521) | 2.17158983 |
| 84 | Increased circulating renin level (HP:0000848) | 2.14848212 |
| 85 | Gait ataxia (HP:0002066) | 2.12227340 |
| 86 | Pheochromocytoma (HP:0002666) | 2.09178851 |
| 87 | Incomplete penetrance (HP:0003829) | 2.04398635 |
| 88 | Abnormality of saccadic eye movements (HP:0000570) | 2.04290551 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.01461986 |
| 90 | Choreoathetosis (HP:0001266) | 2.00993855 |
| 91 | Resting tremor (HP:0002322) | 2.00854060 |
| 92 | Split foot (HP:0001839) | 1.99151071 |
| 93 | Agitation (HP:0000713) | 1.97024536 |
| 94 | Aqueductal stenosis (HP:0002410) | 1.95421296 |
| 95 | CNS hypomyelination (HP:0003429) | 1.94769550 |
| 96 | Obstructive sleep apnea (HP:0002870) | 1.93988879 |
| 97 | Inability to walk (HP:0002540) | 1.92977355 |
| 98 | Generalized myoclonic seizures (HP:0002123) | 1.90548089 |
| 99 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.90056344 |
| 100 | Aplasia of the phalanges of the hand (HP:0009802) | 1.90056344 |
| 101 | Aplasia involving bones of the extremities (HP:0009825) | 1.90056344 |
| 102 | Abnormality of the periventricular white matter (HP:0002518) | 1.86314528 |
| 103 | Neuroendocrine neoplasm (HP:0100634) | 1.82355758 |
| 104 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81679489 |
| 105 | Abnormal EKG (HP:0003115) | 1.81567866 |
| 106 | Spastic tetraplegia (HP:0002510) | 1.81116105 |
| 107 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.80952446 |
| 108 | Rigidity (HP:0002063) | 1.80483556 |
| 109 | Lower limb asymmetry (HP:0100559) | 1.80337913 |
| 110 | Apathy (HP:0000741) | 1.80293763 |
| 111 | Paraplegia (HP:0010550) | 1.79068610 |
| 112 | Lower limb amyotrophy (HP:0007210) | 1.77465182 |
| 113 | Spastic paraplegia (HP:0001258) | 1.77448531 |
| 114 | Blue irides (HP:0000635) | 1.77222644 |
| 115 | Anosmia (HP:0000458) | 1.76119835 |
| 116 | Tetraplegia (HP:0002445) | 1.74292202 |
| 117 | Rapidly progressive (HP:0003678) | 1.74147642 |
| 118 | Ankyloglossia (HP:0010296) | 1.72866909 |
| 119 | Hypoplasia of the corpus callosum (HP:0002079) | 1.72559514 |
| 120 | Iris hypopigmentation (HP:0007730) | 1.70456745 |
| 121 | Protruding tongue (HP:0010808) | 1.69910217 |
| 122 | Thickened helices (HP:0000391) | 1.69885475 |
| 123 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.69701170 |
| 124 | Alacrima (HP:0000522) | 1.67936474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.38668749 |
| 2 | EPHA4 | 4.25448141 |
| 3 | MAP3K9 | 3.82153351 |
| 4 | MAP3K4 | 2.90378976 |
| 5 | MARK1 | 2.90211431 |
| 6 | DAPK2 | 2.84556215 |
| 7 | PRKD3 | 2.74720212 |
| 8 | MINK1 | 2.67813046 |
| 9 | PAK6 | 2.52016793 |
| 10 | NTRK2 | 2.33730569 |
| 11 | MAP2K7 | 2.21274571 |
| 12 | KSR2 | 2.19766427 |
| 13 | CAMKK1 | 2.17148673 |
| 14 | NTRK1 | 2.06429894 |
| 15 | STK38 | 1.80317204 |
| 16 | MAP2K4 | 1.71638156 |
| 17 | RIPK4 | 1.69270344 |
| 18 | CDK5 | 1.62359290 |
| 19 | RIPK1 | 1.50492555 |
| 20 | DAPK1 | 1.45253594 |
| 21 | MAP3K12 | 1.40945434 |
| 22 | KSR1 | 1.40251138 |
| 23 | CDK19 | 1.37831080 |
| 24 | TNIK | 1.36958440 |
| 25 | PRPF4B | 1.35874697 |
| 26 | MAP3K2 | 1.27931578 |
| 27 | PNCK | 1.25254775 |
| 28 | TYRO3 | 1.24748971 |
| 29 | PINK1 | 1.24381998 |
| 30 | GRK5 | 1.22721934 |
| 31 | PRKCG | 1.22689061 |
| 32 | LMTK2 | 1.22395485 |
| 33 | FRK | 1.19198671 |
| 34 | MAPK13 | 1.18133781 |
| 35 | CAMKK2 | 1.17802961 |
| 36 | CASK | 1.16074512 |
| 37 | UHMK1 | 1.12058342 |
| 38 | TAOK1 | 1.11439694 |
| 39 | PLK2 | 1.10944545 |
| 40 | STK11 | 1.09538165 |
| 41 | SIK2 | 1.04473908 |
| 42 | ARAF | 1.03798077 |
| 43 | MAP3K13 | 1.03166767 |
| 44 | PHKG1 | 1.02487297 |
| 45 | PHKG2 | 1.02487297 |
| 46 | FES | 1.00630817 |
| 47 | CAMK1 | 0.98201523 |
| 48 | PRKCH | 0.94080652 |
| 49 | LATS2 | 0.93338523 |
| 50 | ALK | 0.91946239 |
| 51 | SGK223 | 0.90223854 |
| 52 | SGK494 | 0.90223854 |
| 53 | RET | 0.87833530 |
| 54 | CAMK2A | 0.87571830 |
| 55 | CDK15 | 0.86661276 |
| 56 | CDK18 | 0.86022319 |
| 57 | OXSR1 | 0.82203484 |
| 58 | NEK1 | 0.82007130 |
| 59 | CDK14 | 0.80488698 |
| 60 | MAPK12 | 0.78111752 |
| 61 | PAK3 | 0.75427287 |
| 62 | MARK2 | 0.74405462 |
| 63 | CDK11A | 0.74257424 |
| 64 | PDK1 | 0.70671127 |
| 65 | SGK1 | 0.69872770 |
| 66 | RAF1 | 0.68928568 |
| 67 | WNK1 | 0.68900593 |
| 68 | PTK2B | 0.67787950 |
| 69 | CAMK2B | 0.67356509 |
| 70 | SGK2 | 0.65336681 |
| 71 | CSNK1G2 | 0.64814441 |
| 72 | SGK3 | 0.64621648 |
| 73 | PDPK1 | 0.64554909 |
| 74 | MAP3K1 | 0.63257132 |
| 75 | TNK2 | 0.61410468 |
| 76 | DYRK1A | 0.61129580 |
| 77 | SCYL2 | 0.59915819 |
| 78 | CAMK1G | 0.59871424 |
| 79 | BMPR2 | 0.57701524 |
| 80 | CDC42BPA | 0.55802486 |
| 81 | MAP3K7 | 0.54007111 |
| 82 | RPS6KA3 | 0.53324921 |
| 83 | NEK6 | 0.52917598 |
| 84 | PRKCZ | 0.51949213 |
| 85 | FYN | 0.49621836 |
| 86 | FER | 0.47796818 |
| 87 | IRAK2 | 0.47364509 |
| 88 | BRSK1 | 0.47219382 |
| 89 | CAMK4 | 0.46268026 |
| 90 | MAPK10 | 0.46065401 |
| 91 | PRKCE | 0.43686567 |
| 92 | CAMK2G | 0.43193792 |
| 93 | FGFR2 | 0.42645484 |
| 94 | DAPK3 | 0.42378324 |
| 95 | PRKG1 | 0.42094115 |
| 96 | PDGFRA | 0.41181817 |
| 97 | PRKCA | 0.40714256 |
| 98 | STK39 | 0.39776791 |
| 99 | LIMK1 | 0.39642510 |
| 100 | MAP3K11 | 0.38702887 |
| 101 | CAMK2D | 0.38406215 |
| 102 | PRKD2 | 0.37409127 |
| 103 | ICK | 0.36680450 |
| 104 | CSNK1D | 0.36194870 |
| 105 | PRKACA | 0.33850770 |
| 106 | CCNB1 | 0.33086189 |
| 107 | PKN1 | 0.32657391 |
| 108 | ROCK2 | 0.32526503 |
| 109 | PRKCB | 0.32495793 |
| 110 | ERBB2 | 0.31786960 |
| 111 | MAPK8 | 0.31769191 |
| 112 | MAPKAPK5 | 0.30166749 |
| 113 | DYRK2 | 0.28615835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.42782590 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.25890563 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.78476515 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.74714630 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65105622 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.63331140 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.59955437 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.55919633 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.41908166 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38294995 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.29628708 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.22515154 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.14935589 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.06185209 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.95295664 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94350977 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89709871 |
| 18 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73311295 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.67483649 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.66129642 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.62980602 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61187539 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58198580 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.54841259 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52512115 |
| 26 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.47577430 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.47505753 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46846247 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.40262182 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35235146 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.34603583 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.34460556 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.30340195 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.25534127 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24698872 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.20686056 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.16502505 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.15467829 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12647322 |
| 40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.11671266 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.06168210 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04989662 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.02782457 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 1.01287069 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.98083354 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96662418 |
| 47 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96649606 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94590429 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91479129 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89750677 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85004088 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83988462 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81986309 |
| 54 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80773848 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76969434 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76961275 |
| 57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75458756 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73444667 |
| 59 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70065781 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70058565 |
| 61 | Phototransduction_Homo sapiens_hsa04744 | 0.69237014 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67287894 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64639008 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64510451 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63298567 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63247848 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59729872 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59453493 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.59249347 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58990866 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58878683 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.58577908 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57801077 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57342193 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54904374 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49414263 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47420484 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.46994238 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46824446 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45973455 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45801695 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45785292 |
| 83 | Alcoholism_Homo sapiens_hsa05034 | 0.45662247 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45134704 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43296202 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43287114 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43160123 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41830333 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.41645115 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41396115 |
| 91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39668144 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39236200 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38464815 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37569491 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.37246722 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.37133296 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36706176 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36273530 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35742740 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35489060 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.34888318 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34447451 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32570599 |
| 104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31189267 |
| 105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30672074 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30214756 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29848203 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.27453505 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.27387129 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26050655 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.24923161 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.21666198 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19234675 |

